We have developed a high‐throughput progenitor cell‐derived basophil activation test (PCBAT), which was a better predictor of clinical reactivity to cat and peanut allergen (as measured on challenge testing) than conventional markers of allergy such as SPT or allergen specific IgE. This evidence concerns the gene IGHE and allergic disease.